HIV fusion and its inhibition

Antiviral Res. 2001 May;50(2):95-115. doi: 10.1016/s0166-3542(01)00130-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • CD4 Immunoadhesins / pharmacology
  • CD4 Immunoadhesins / therapeutic use
  • Enfuvirtide
  • HIV / drug effects*
  • HIV / physiology
  • HIV Envelope Protein gp41 / pharmacology
  • HIV Envelope Protein gp41 / therapeutic use
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • Heterocyclic Compounds / pharmacology
  • Heterocyclic Compounds / therapeutic use
  • Humans
  • Membrane Fusion / drug effects*
  • Peptide Fragments / pharmacology
  • Peptide Fragments / therapeutic use
  • Receptors, HIV / drug effects
  • Receptors, HIV / metabolism*

Substances

  • Anti-HIV Agents
  • CD4 Immunoadhesins
  • CD4-IgG(2)
  • HIV Envelope Protein gp41
  • Heterocyclic Compounds
  • Peptide Fragments
  • Receptors, HIV
  • Enfuvirtide
  • plerixafor octahydrochloride